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Abstract
Background: To study different imaging criteria for prediction of lymph node metastases (Stage III disease) in
colon cancer using CT.
Methods: In a retrospective setting, 483 consecutive patients with histology proven colon cancer underwent
elective primary resection during 2008–2011, a cohort of 119 patients were included. Contrast enhanced CT
examinations, in portal-venous phase, were reviewed with assessment of the number of lymph nodes, their
anatomical distribution, size, size ratio, internal heterogeneity, presence of irregular outer border and attenuation
values. Sensitivity, specificity, PPV and NPV for each studied criteria for prediction of stage III disease was calculated.
Results: According to histopathology 80 patients were stage I-II and 39 were stage III. Of the studied CT-criteria for
lymph node metastases per patient, internal heterogeneity in at least one lymph node resulted in the best
performance with sensitivity, specificity, PPV and NPV of 79, 84, 70 and 89%, Odds ratio (OR) 20. Presence of
irregular outer border resulted in a sensitivity, specificity, PPV and NPV of 59, 81, 61 and 82%, OR 6.2. If both internal
heterogeneity and/or irregular outer border was used as a criterion this resulted in a sensitivity, specificity, PPV and
NPV of 85, 75, 62 and 91%, OR 16.5. None of the size criteria used were predictive for stage III disease.
Conclusions: When performing preoperative CT in patients with colon cancer, the imaging criteria that allow best
prediction of stage III disease on CT are either presence of at least one lymph node with internal heterogeneity or
internal heterogeneity and/or irregular outer border. These criteria have to be validated in a prospective study.
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Background
Colon cancer is the third most common malignancy in
the western world. In Sweden the incidence is increasing
with an aging population while the mortality is slowly
decreasing [1].
The treatment is surgical removal of the tumour con-
taining segment of the bowel together with local and re-
gional lymph nodes. In addition, adjuvant chemotherapy
is standard treatment for patients with stage III disease
and in some patients with stage II disease, depending on
presence of additional histological risk factors.
Well-known important prognostic factors in colon
cancer are tumour stage (T), extramural vascular inva-
sion (EMVI) and lymph node involvement (N) [2]. Even
the total number of harvested lymph nodes at surgery
and lymph node ratio (the ratio between lymph node
metastases and examined lymph nodes, LNR) assessed
by the pathologist has a prognostic importance [3–5].
A complete preoperative evaluation of patients with
colon cancer includes staging of the primary tumour and
evaluation of distant metastases in the liver and lungs with
computed tomography (CT). In recent years, some studies
advocate and support the use of CT also for local staging
of colon cancer including treatment planning and selection
of patients for neoadjuvant treatment [6–8]. If selection of
patients for neoadjuvant treatment is being used routinely
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in the clinic, pretreatment knowledge of regional lymph
node involvement will be even more important.
To date, there are no validated imaging criteria for the
assessment of lymph node metastases in colon cancer.
Previous studies have applied different criteria based on
either size and/or morphology. Lymph node size >1 cm,
short-long axis diameter ratio, internal heterogeneity (IH),
irregular outer border (IOB), attenuation values >100
Hounsfield units (HU) and cluster of three or more nor-
mal sized lymph nodes, or any combination of the above,
have all been used as a single criterion or combined
criteria [6, 9–14]. In a systematic review by Leufkens et al.
including 753 patients with colon cancer in altogether 11
studies a sample sized weighted sensitivity and specificity
of CT for N-staging of 76 and 55% was reported [15].
Most of the studies included were performed with older
CT-technology that is no longer used and that does not
allow true multiplanar assessment. Furthermore, the stud-
ies did not consider the distribution and location of lymph
nodes within the colonic mesentery adjacent to the cancer
as a potential marker of lymph node involvement.
Today, when CT scanners are configured with multiple
rows of detectors, multiplanar assessment can be per-
formed allowing for more detailed assessment of size
and morphology of pathological lesions [16].
The aim of this study was to assess whether the num-
ber of lymph nodes, their anatomical distribution, size,
size ratio, internal heterogeneity, irregular outer border
and attenuation values on preoperative CT, either alone
or in combination, were predictive for stage III disease.
Methods
From the Swedish colorectal cancer registry (SCRCR), 483
consecutive patients having a histology proven colon can-
cer and operated between the years 2008 and 2011 and ex-
amined with abdominal CT (64 detector CT-scanner)
before surgery at our institution were included. A cohort
of 119 patients was determined, after the following patients
were excluded: insufficient CT examination (no iv contrast,
CT-Colonography, no 64-slice) including examination per-
formed outside the University hospital (n = 80), patients
having emergency colonic surgery (n = 78), patients with
T4 tumours (n = 68), metastatic disease (n = 67), no detect-
able tumour on the preoperative CT (n = 18), co-malignant
disease (n = 15), CT examination >60 days prior to surgery
(n = 13), patients with neo-adjuvant chemotherapy (n = 11),
previous colon cancer surgery (n = 9), CT after treatment
with colon stenting (n = 3) and perforated tumour or
abscess (n = 2).
In the remaining cohort with histologically proven
colon cancer there were 63 women and 56 men with a
median age of 69 (range 32–91 years).
Most of the tumours were located in the sigmoid colon
(Table 1). The majority of the tumors were classified on
histopathology as T3 tumours (Table 1). Thirty-nine out of
119 patients had lymph node positive (stage III) disease (28
patients N1 and 11 patients N2) (Table 1). The median age
for patients with stage I-II disease was 70 years, and the
median age for patients with stage III disease was 63 years.
All patients had preoperative investigations with CT of
the abdomen with intravenous contrast (0.5 mg Iodine/
kg) in portal-venous phase (delay 90 s) on one of four
different 64 slice CT scanners (Lightspeed VCT, General
Electric, Milwaukee, USA). All examinations were per-
formed at 120 kV and with tube current modulation. For
abdomen the median dose length product (DLP) was
583 mGy-cm (range 393 to 878 mGy-cm). Median pitch
factor was 1.375 (range 0.516 to 1.50). Medium noise
Table 1 Demographics table of 119 patients/tumours
Characteristics Number (%)
Sex (female/male) 63/56




Ascending colon 22 (18%)
Hepatic flexure 8 (7%)
Transverse colon 11 (9%)
Splenic flexure 4 (3%)
Descending colon 6 (5%)





Positive lymph node status
T1 tumours 2/10 (20%)
T2 tumours 2/16 (12%)
T3 tumours 35/93 (38%)
Stage
Stage I 22 (18%)
Stage II 58 (49%)
Stage III 39 (33%)
Lymph nodes, total number
Harvested lymph nodes PAD 2542
Positive lymph nodes PAD 123
CT evaluation
Detected lymph nodes ≥4 mm/tot 442/1312 (34%)
Region 1 261/835 (31%)
Region 2 161/389 (41%)
Region 3 20/88 (23%)
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index was 30 (range 26 to 42). The variation in both
pitch factor and noise index are due to differences in the
four CT scanners that were used. In 56 CT examinations
arterial phase imaging of the abdomen at the tumour
location and liver was also performed. After the examin-
ation, reformatted images in axial, coronal and sagittal
planes with 5 mm thickness (increment 2.5 mm) were
routinely generated together with the original (thin
slices) 0.625 mm images.
CT evaluation
All CT examinations were retrospectively reviewed by
one radiologist (E.R.) with more than 15 years of experi-
ence in cross sectional imaging of colorectal cancer and
blinded for the histology and surgical reports. Examina-
tions were assessed according to a dedicated evaluation
proforma.
All measurements and assessments were performed on
a Sectra Workstation IDS7 (version 15.1.14.41) using the
5 mm reformatted images with 2.5 mm increment. The
original thin slices (0.625 mm) were used for detection
of small lymph nodes (≤4 mm).
Anatomical distribution
The colonic mesentery, 5 cm oral and aboral from the
tumour site, was divided in three anatomical regions
(region 1–3), as a modified variant of the guidelines of
the Japanese Society for Cancer in the Colon and
Rectum [17]. Region 1 was defined as the region most
adjacent to the tumour (+/−5 cm) and 3 cm proximal
along the vessels to the branch artery divides covering
the pericolonic and marginal lymph nodes. Region 3 was
defined as the most proximal part of the mesentery
including the undivided mesenteric artery from the aorta
(proximal lymph nodes). Region 2 was defined as the
region between region 1 and 3 (Fig. 1).
Number, size and size-ratio of lymph nodes
All lymph nodes ≥2 mm in size were separately registered
in total and in each anatomical region. For lymph nodes
≥4 mm in shortest diameter, the short axis and the long
axis were also separately measured and the ratio between
the short and long axis diameter was calculated. The size
ratio (ratio between two orthogonal (short/long) axis di-
ameters) was used to test whether a more rounded shape
was predictive for metastasis. A >0.8 ratio between diam-
eter was used as cut off point according to a previous
study [18]. The presence of a cluster (within a range of the
lymph node diameter) of three or more lymph nodes was
also separately noted in every region.
Internal heterogeneity and irregular outer borders
As possible morphological predictors of metastases, the
internal heterogeneity (IH, mixed attenuation within the
lymph node) as well as the irregular outer border (IOB,
indistinct demarcation of the lymph node) were evaluated
both on reformatted and thin sections (Figs. 2 and 3).
Attenuation values
Attenuation measurements of each lymph node in the
portal venous phase and, when available, in the arterial
phase were also performed. All density measurements
(using HU) were performed by placing as large a region
of interest (ROI) as possible (>2 mm2) on the lymph
node in the portal venous phase and in the arterial phase
when available. Attenuation values of ≥50 and ≥100 HU
in the portal venous phase were separately noted as well
as ratio portal venous/arterial phase. Inhomogeneous
contrast enhancement as indicative for tumour involve-
ment was separated from either presence of a fatty
lymph node hilum or a contrast filled vessel in the vicin-
ity of a lymph node.
Surgery
All patients in the study were operated in an elective
setting and according to colorectal surgery praxis. The
resection of colon cancer was made by clear lateral mar-
gins, resection of the loco-regional lymph node bearing
mesentery.
Fig. 1 Assessment of right and left sided tumours (T) and their
corresponding anatomical distribution of lymph nodes. Region 1
(yellow) is +/− 5 cm oral and aboral near the tumour site and
approximately 3 cm along the feeding arterial branch to the nearest
arterial vessel division. Region 3 (blue) is the undivided artery from
the aorta (superior mesenteric artery (SMA) or inferior mesenteric
artery (IMA)) to the first artery division. Region 2 (green) is between
regions 1 and 3
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Histopathology
Histopathology was performed according to standard
procedures at the university hospital pathology depart-
ment by a specialized GI pathologist (initially using
TNM version 6 and later TNM version 7) [19, 20]. From
the pathologists’ original report the T- and N-stage, the
total number of harvested and metastatic lymph nodes
served as reference standard.
Statistics
Data were evaluated using statistical analysis software
SPSS, IBM. Descriptive statistics were applied to the
different lymph node characteristics calculating sensitiv-
ity, specificity, PPV, NPV and Odds ratio for the predic-
tion of stage III disease. Mann–Whitney U test were
used to test significance which was set to p ≤ 0.05.
Univariate and multiple logistic regression analyses were
performed for categorical data. Receiver operating char-
acteristics (ROC) and area under the curve (AUC) were
used to compare the optimal lymph node size criterion.
Results
Patients and histopathology
The median time interval between pre-operative CT
examination and surgery was 28 days (range 4 – 59 days),
mean 29 days (standard deviation 13 days).
A total of 2542 lymph nodes were harvested (median
19 lymph nodes/patient, range 4–69) and of those 123
were assessed as metastases (median, 2 lymph nodes/pa-
tient, range 1–10). The change from TNM 6 to TNM 7
did not affect the result.
CT evaluation
Number, anatomical distribution, size and size-ratio of
lymph nodes
At CT, most of the lymph nodes were located in region 1.
Region 2 had higher proportion of lymph nodes ≥4 mm
(41%) compared to the other regions (Table 1). The mean
number of lymph nodes found was 7.2 for pT1 tu-
mours, 8.6 for pT2 tumours and 11.8 for pT3 tumours
(not shown in Table).
Evaluation of lymph nodes
Using size thresholds of ≥4, 5, 6, 7, 8 and 10 mm as
criteria for lymph node metastases, the results are pre-
sented as a ROC-curve in Fig. 4.
Size ratio with a cutoff point of 0.8 had an overall sen-
sitivity and specificity of 85 and 30% (Table 2). If divided
into the three anatomical regions, the sensitivity and
specificity were as follows: region 1, 80 and 35%; region
2, 54 and 74% and region 3, 5 and 94%, respectively.
Fig. 3 Transaxial reformation (5 mm section post iv contrast portal
phase) CT image illustrating the apperance of a 7 × 7 mm mesocolic
lymph node (white arrow) in region 2 with irregular outer border
and internal heterogeneity in a patient with a pT3 tumour in the
sigmoid colon with 1 metastatic lymph nodes out of 16 harvested
at histopathology
Fig. 2 Coronal reformation (5 mm section post iv contrast portal
phase) CT image illustrating the apperance of 10 × 15 mm lymph node
(white arrow) in region 1 with internal heterogeneity thus well defined
borders in a patient with pT3 tumour in the ascending colon. At
histopathology, 4 metastatic lymph nodes out of 43 were harvested
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Internal heterogeneity and irregular outer border
Forty-four out of 119 patients had at least one (range 1–6)
lymph node with internal heterogeneity according to CT
and a total number of 94 lymph nodes with this morpho-
logical feature were detected. Compared to histopath-
ology, the sensitivity and specificity for predicting stage III
disease with this criterion was 79 and 84%, respectively,
p ≤ < .001, OR = 20 (Table 2). If divided by anatomical
region, the sensitivity and specificity were as follows: re-
gion 1, 64 and 91%; region 2, 51 and 92% and region 3, 3
and 97%, respectively.
Thirty-eight patients had at least one (range 1–8)
lymph node with an irregular outer border.
Compared to histopathology, lymph nodes with an
irregular outer border showed sensitivity and specificity
for prediction of stage III disease of 59 and 81%,
respectively, p ≤ < .001, OR = 6.3 (Table 2). If divided
by anatomical region, the sensitivity and specificity
were as follows: region 1, 49 and 89%; region 2, 33
and 91%, and region 3, 0 and 99%, respectively.
In patients with at least one lymph node with internal
heterogeneity and a lymph node with an irregular outer
border, regardless of location, the sensitivity and specifi-
city for stage III disease was 54 and 90%, respectively.
Patients with any lymph node showing internal hetero-
geneity and/or irregular outer borders, meaning that
either one of the criteria were present or both in com-
bination, showed an overall sensitivity and specificity for
stage III disease of 85 and 75%,respectively, p ≤ < .001,
OR = 16.5 (Table 2).
Contrast enhancement
The overall sensitivity and specificity prediction of stage III
disease for lymph nodes having a HU value ≥50 or ≥100
Fig. 4 Size criteria (≥4, 5, 6, 7, 8, 10 mm) in shortest diameter according to CT presented as receiver operating characteristics, ROC, and Area
under the curve, AUC
Table 2 Sensitivity, specificity, PPV and NPV (%) for the different CT characteristics of lymph nodes > 4 mm in shortest diameter
Variables Number Sensitivity Specificity PPV NPV OR p-value
Size ≥5 mm 287 90 31 39 86 1.33 0.002
Size ≥10 mm 29 28 90 58 72 2.67 0.009
Ratio cut off 0.8 244 85 30 37 80 2.36 0.090
Internal heterogeneity (IH) 94 79 84 70 89 20.0 <0.001
Irregular outer border (IOB) 73 59 81 61 82 6.23 <0.001
IH and/or IOB 67 85 75 62 91 16.5 <0.001
HU ≥50 396 95 20 37 89 4.63 0.049
HU ≥100 81 44 68 40 71 1.60 0.239
Cluster of three 14 13 89 36 68 1.16 0.803
Note: HU Hounsfield units, OR Odds ratio
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post contrast in portal venous phase were, 95 and 20%,
and 44 and 68%, respectively (Table 2).
Cluster of three or more normal shaped and sized lymph
nodes
This criterion resulted in an overall sensitivity of 13%
and a specificity of 89% (Table 2).
Combination of different variables using multivariate
logistic regression analyses
The strongest predictor for stage III disease in our
study was internal heterogeneity. No other variable
contributed significantly when the variable internal het-
erogeneity was included in the multivariate regression
model (Fig. 5).
Discussion
To our knowledge, this report is the first to study previ-
ously reported criteria for lymph node metastases on CT
separately or in comparison as a predictor for stage III
disease in colon.
Of all the studied imaging criteria in this study, mor-
phological criteria was superior to size criteria. Internal
heterogeneity and irregular outer borders were the two
variables that display best, both alone or combined, with
reasonable sensitivity and specificity. The combination
of internal heterogeneity and/or irregular outer borders
still resulted in a moderate sensitivity of 85% and specifi-
city of 75%. The strongest predictor in our study for
stage III disease was internal heterogeneity both alone or
combined with other variables (Fig. 5). Our results using
CT are inferior, but for sensitivity comparable with pre-
vious work by Brown et al., which used morphological
predictors for mesorectal lymph node status in magnetic
resonance imaging (MRI) of rectal cancer where
mixed signal intensity or irregular border resulted in
a sensitivity of 85% and specificity of 97% [21].
The majority (64%) of lymph nodes that were detected,
regardless of N-stage, were located in region 1, but pres-
ence of lymph nodes in this region were not predictive for
nodal disease (stage III) (p = 0.182). In region 2 there was
a slightly higher proportion of lymph nodes in favour of
stage III (160 out of 471 lymph nodes (34%)) vs stage II
(229 out of 841 lymph nodes (27%)) (p = 0.006). In the
whole cohort, only 39 patients had lymph nodes in region
3, and there was no difference between the two groups
regardless of T-stage. The high specificity in region 3 for
the criteria internal homogeneity, irregular outer border
and size ratio cut off <0.8 is due to a very limited number
of lymph nodes fulfilling those criteria.
In a study, with 106 patients and up to date com-
puted tomography technique using >1 cm and/or
cluster of ≥3 lymph nodes as criteria for nodal dis-
ease resulted in a sensitivity of 71% and specificity of
41% [22]. In the present study, only 19 patients had
lymph nodes ≥10 mm and only 14 patients had
lymph nodes in a cluster of three, thus reducing the
impact of these criteria for prediction of stage III.
Regarding lymph node size, lymph nodes >5 mm and/
or irregular outer border were considered positive for
nodal disease in the study by Dighe et al. with sensitivity
and specificity of 64 and 53%, respectively [8]. In our
study, this criterion showed a similar sensitivity of 56%
but a higher specificity of 84%. We have no explanation
for this difference.
Size criteria alone can really be questioned and not
supported by our study. It has been reported that up to
70% of lymph nodes with metastases in colorectal cancer
Fig. 5 Multivariate logistic regression analyses for odds ratio of different lymph node characteristics when internal heterogeneity is
included in the model
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are ≤5 mm in diameter [23]. The majority of the detected
lymph nodes (n = 870, 66%) in our study were <4 mm and
thus could not be further assessed because of their small
size and uncertainty in characterization using CT.
In the study of Kwak et al., a combination of criteria
regarding assessment of lymph node metastases, includ-
ing a cluster of more than three nodes along the loco-
regional vascular pedicle, spiculated and indistinct node
borders, and a mottled heterogeneous pattern were all
integrated in the assessment and together with the size
threshold of ≥10 mm reporting a sensitivity and specificity
of 87 and 29%, respectively, with CT alone [24]. The speci-
ficity was surprisingly low maybe due to the large thresh-
old size. The results with positron emission tomography/
computed tomography (PET/CT), with a slightly different
setting of defined criteria, did not markedly improve the
overall results with a sensitivity and specificity of 66 and
60%, respectively.
Other studies using fluoro-2-deoxy-D-glucose-PET
(FDG-PET) reported low sensitivities (29–37%) but
higher specificity (87%) for nodal staging, suggesting that
PET/CT is of limited additional value in detecting meta-
static regional lymph nodes surrounding the primary
tumour due to high false negative rate [25, 26]. Some
authors argues that routine use of PET/CT can alter or
change the management in stage III patients (6.5%) and
stage IV patients (12.7%) while other authors claim that
it does not [27, 28].
Regarding contrast enhancement/attenuation features,
this does not seem to increase diagnostic accuracy.
Arterial or portal venous phase attenuation post contrast
was not predictive for stage III disease in this study. The
differences in attenuation between arterial and portal-
venous phase was not predictive for stage III disease.
Furthermore, regarding lymph node size ratio, Kanamoto
et al. reported both high sensitivity and specificity of 87
and 80%, respectively, using the criteria of cutoff point of
0.8 or greater in short/long axis diameter ratio measured
in the axial plane of the CT images [18]. In this current
study the reformatted images were used to measure the
true short and long axis and found similar sensitivity (85%)
for this criterion but much lower specificity (30%) due to a
high rate of false positive findings (70%). Benign lymph
nodes can be either oval or rounded, which is a limitation
using this criterion.
The use of CT assessed lymph node status alone as
predictor of prognosis is still premature. If selection for
neoadjuvant chemotherapy was made by the best combin-
ation of criteria (heterogeneity and/or irregular border) in
this study, 6 patients out of 39 (15%) would potentially be
undertreated and 20 patients out of 80 (25%) overtreated.
This emphasizes the need to decide on such treatment
based on other prognostic factors or use them in combin-
ation with the assessed lymph node status.
The strength of this study, beside the use of several
imaging criteria for lymph node metastases, is the
homogenous patient cohort; all examined with 64-
multidetector CT and all having primary surgery allowing
histopathology of the resected specimen as reference.
Limitations of the study were the retrospective set-
ting. The assessment by only one observer could reduce
the robustness and reproducibility of the imaging cri-
teria. These criteria must be validated in a multi reader
setting. There were also a limited number of patients
with some of the criteria. Furthermore, the histopatho-
logical tissues were not reevaluated and there was no
possibility to match individual lymph nodes between
imaging and histopathology. Another possible limita-
tion was that we also excluded T4 tumours in the
study. We argue that the high rate of lymph node
metastases in this group of patients (around 37%) is
likely to bias the radiologist when looking on CT and
assessing the lymph nodes. No texture analysis software
was available at the time of the study. We believe that
texture analysis may have a role in the context of char-
acterizing regional lymph nodes on CT in colon cancer
although the approach in this setting is rather unex-
plored and may be subjected to a separate study.
Conclusion
Various imaging criteria for lymph node metastases on
CT have been used in previous literature. The results of
the present study do not support use of any the com-
monly used criteria for lymph node metastases. When
performing preoperative CT in patients with colon can-
cer, the imaging criteria that allow the best prediction of
stage III disease are either the presence of at least one
lymph node with internal heterogeneity or the presence
of at least one lymph node with internal heterogeneity
and/or irregular outer border. These criteria have to be
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